Skip to main content

Vaxart, Inc.

VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000072444

No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Vaxart, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of VXRT: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders11196−15
Shares28.9M18.5M−10.5M (−36.1%)
Value$21.1M$13.9M−$7.19M (−34.1%)

New holders (8)

Institutions that held Vaxart, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to VXRT in Q3 2023
InstitutionSharesValue% of portfolio
Private Portfolio Partners LLC111,670$84.2K0.02%
JustInvest LLC27,570$20.8K0.00%
Kestra Private Wealth Services, LLC24,000$18.1K0.00%
Squarepoint Ops LLC19,425$14.6K0.00%
Wealth Enhancement Advisory Services, LLC11,006$8.30K0.00%
Mariner, LLC10,162$7.66K0.00%
PFG Private Wealth Management, LLC30$230.00%
NBC Securities, Inc.800$00.00%

Sold out (23)

Institutions that held Vaxart, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.